MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Behavioral Phenotype of a Mouse Model of Mixed Movement Disorders Linked to ADCY5

    J. Baik, E. Conabady, M. Doulazmi, R. Yuan, C. Dubacq, E. Roze (Paris, France)

    Objective: To define the motor and non-motor phenotypic features of a novel Adcy5R419W mouse line [1] and validate it as an integrated model of human mixed movement disorders…
  • 2026 International Congress

    Cannabis-based Oil for Pain and Other Non-motor Symptoms in Parkinson’s Disease: a Randomized Controlled Trial

    A. Alves, J. Parmera, G. Kubota, P. Martins, M. Deltreggia, A. Falcone, A. Santana, M. Falcão, M. Dias, L. Moreira, P. Filho, E. Figueiredo, E. Barbosa, R. Cury, D. Andrade (São Paulo, Brazil)

    Objective: To assess the safety, tolerance, and effectiveness of an oil extract of Cannabis sativa L. on pain and other non-motor symptoms (NMS) in people…
  • 2026 International Congress

    Real-World Clinical Outcomes and Patient Experience Following Hybrid DBS Conversion to a Neurostimulator with Advanced Current Steering

    J. Vesper, A. Dreyer, R. Shivacharan, E. Goldberg (Düsseldorf, Germany)

    Objective: In this report, we describe preliminary real-world clinical outcomes and patient experience following hybrid DBS conversion procedures at our center. Background: Hybrid replacement procedures…
  • 2026 International Congress

    Delayed-Onset Rapidly Progressive Parkinsonism After BCMA×CD3 Bispecific Antibody Therapy: A Case Report

    IF. Yang, TY. Chung, YF. Sung (Taipei, Taiwan)

    Objective: To describe a delayed-onset rapidly progressive parkinsonian syndrome with encephalopathy following BCMA×CD3 bispecific antibody therapy. Background: B-cell maturation antigen (BCMA) × CD3 bispecific antibodies…
  • 2026 International Congress

    Neuroprotective Effects of Curcumin on Hippocampal-PPN Circuitry in a Rotenone-Induced Rat Model of Parkinson’s Disease

    L. Darbinyan, L. Hambardzumyan, L. Manukyan, M. Danielyan, K. Karapetyan, K. Simonyan (Yerevan, Armenia)

    Objective: This study investigated the neuroprotective effects of curcumin on the hippocampal-pedunculopontine nucleus (PPN) axis in a rotenone-induced rat model of PD. Background: Parkinson’s disease…
  • 2026 International Congress

    Predictors of Severity of Psychosis in Parkinson’s Disease: A 3-year longitudinal cohort study

    R. Sharma, J. Flanigan, B. Shah, J. Patrie (Charlottesville, USA)

    Objective: To determine which disease-related variables are independently associated with severity of psychosis in Parkinson’s Disease. Background: Parkinson’s disease (PD) is a multisystem disorder in…
  • 2026 International Congress

    Risk of Ischemic Cerebrovascular Events in Patients with Deep Brain Stimulation for Parkinson’s Disease: A Cohort Study

    P. Antenucci, M. Paciaroni, A. Gozzi, A. Mechelli, M. Pugliatti, D. Gragnaniello, M. Sensi (Ferrara, Italy)

    Objective: To longitudinally assess the risk of ischemic cerebrovascular events in patients undergoing DBS Background: Longitudinal data on the potential impact of DBS on long-term…
  • 2026 International Congress

    Association Between Step Count Change Rate During Dual Task Timed Up and Go and Balance Components in Parkinson’s Disease

    Y. Yamazaki, T. Nakamura, K. Watanabe, G. Horiguchi, S. Kishimoto, H. Miyamoto, Y. Kameyama, E. Kitahara, K. Haruyama, N. Nishikawa, T. Hatano, N. Hattori, T. Fujiwara (Bunkyo-ku, Japan)

    Objective: To identify balance components associated with the step count change rate during dual task Timed Up and Go in patients with Parkinson’s disease Background:…
  • 2026 International Congress

    Skin Biopsy for Phosphorylated Alpha-Synuclein and DAT Imaging in Patients Diagnosed with Psychogenic Parkinsonism

    J. Phillips, V. Evidente, D. Evidente (Phoenix, USA)

    Objective: Objective:Describe the results of skin biopsy for phosphorylated alpha-synuclein (P-SYN) and dopamine transporter (DAT) imaging in patients previously diagnosed with psychogenic parkinsonism (PP) and…
  • 2026 International Congress

    Micrographia in Parkinson’s Disease and Multiple System Atrophy: A Quantitative Tablet-Based Handwriting Study

    Y. Hagiwara, J. Shin, S. Kobayashi (Tokyo, Japan)

    Objective: To evaluate the relative contributions of cognitive and motor factors to handwriting performance in patients with MSA and PD using quantitative tablet-based tasks. Background:…
  • « Previous Page
  • 1
  • …
  • 143
  • 144
  • 145
  • 146
  • 147
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley